Psyrin Secures £1M in Pre-Seed Funding to Revolutionize Mental Health Care with AI and Speech Technology

Psyrin, a groundbreaking London-based startup, has successfully raised £1,000,000 in funding to revolutionize the approach to mental health care, specifically targeting severe mental illnesses like psychosis. With a mission to transform clinical pathways through innovative technology, Psyrin has developed cutting-edge software that leverages the power of speech recognition and artificial intelligence, aiming to set a new standard in assessment and monitoring for patients. This significant investment comes as a testament to the growing recognition of the importance of mental health, particularly in a post-pandemic world where the demand for effective interventions is at an all-time high. The funds raised will be instrumental in further developing Psyrin's advanced platform, which facilitates timely and precise assessments, enabling clinicians to better understand and manage psychotic disorders. By analyzing verbal cues and language patterns, the software not only helps in diagnosing conditions but also enhances ongoing monitoring, ultimately leading to more personalized and effective treatment plans. Supported by the prestigious King's Entrepreneurship Institute, Psyrin is strategically positioned to make a profound impact in the field of mental health care, driving innovation that could change the lives of millions. As the company prepares to roll out its beta version, this funding will accelerate product development, bolster research initiatives, and expand outreach to healthcare professionals across the UK. With this endeavor, Psyrin is not just raising capital; it is embarking on a mission to reshape the future of mental health care through technology that is compassionate, intelligent, and proactive.